Malin Parmar
Cited by
Cited by
Direct conversion of human fibroblasts to dopaminergic neurons
U Pfisterer, A Kirkeby, O Torper, J Wood, J Nelander, A Dufour, ...
Proceedings of the National Academy of Sciences 108 (25), 10343-10348, 2011
Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions
A Kirkeby, S Grealish, DA Wolf, J Nelander, J Wood, M Lundblad, ...
Cell reports 1 (6), 703-714, 2012
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model
T Kikuchi, A Morizane, D Doi, H Magotani, H Onoe, T Hayashi, H Mizuma, ...
Nature 548 (7669), 592-596, 2017
Generation of induced neurons via direct conversion in vivo
O Torper, U Pfisterer, DA Wolf, M Pereira, S Lau, J Jakobsson, ...
Proceedings of the National Academy of Sciences 110 (17), 7038-7043, 2013
Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation
D Doi, B Samata, M Katsukawa, T Kikuchi, A Morizane, Y Ono, ...
Stem cell reports 2 (3), 337-350, 2014
Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson’s disease
S Grealish, E Diguet, A Kirkeby, B Mattsson, A Heuer, Y Bramoulle, ...
Cell stem cell 15 (5), 653-665, 2014
Human trials of stem cell-derived dopamine neurons for Parkinson’s disease: dawn of a new era
RA Barker, M Parmar, L Studer, J Takahashi
Cell stem cell 21 (5), 569-573, 2017
Cell-based therapies for Parkinson disease—past insights and future potential
RA Barker, J Drouin-Ouellet, M Parmar
Nature Reviews Neurology 11 (9), 492-503, 2015
Strengths and limitations of the neurosphere culture system
JB Jensen, M Parmar
Molecular neurobiology 34, 153-161, 2006
Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-based therapy for Parkinson’s disease
A Kirkeby, S Nolbrant, K Tiklova, A Heuer, N Kee, T Cardoso, ...
Cell stem cell 20 (1), 135-148, 2017
The future of stem cell therapies for Parkinson disease
M Parmar, S Grealish, C Henchcliffe
Nature Reviews Neuroscience 21 (2), 103-115, 2020
Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation
S Nolbrant, A Heuer, M Parmar, A Kirkeby
Nature protocols 12 (9), 1962-1979, 2017
Single-cell RNA sequencing reveals midbrain dopamine neuron diversity emerging during mouse brain development
K Tiklová, ÅK Björklund, L Lahti, A Fiorenzano, S Nolbrant, L Gillberg, ...
Nature communications 10 (1), 581, 2019
Advances in stem cell research and therapeutic development
M De Luca, A Aiuti, G Cossu, M Parmar, G Pellegrini, PG Robey
Nature Cell Biology 21 (7), 801-811, 2019
Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2
E Andersson, JB Jensen, M Parmar, F Guillemot, A Bjorklund
Oxford University Press for The Company of Biologists Limited 133 (3), 507-516, 2006
In vivo reprogramming of striatal NG2 glia into functional neurons that integrate into local host circuitry
O Torper, DR Ottosson, M Pereira, S Lau, T Cardoso, S Grealish, ...
Cell reports 12 (3), 474-481, 2015
New approaches for brain repair—from rescue to reprogramming
RA Barker, M Götz, M Parmar
Nature 557 (7705), 329-334, 2018
Identification of embryonic stem cell–derived midbrain dopaminergic neurons for engraftment
YM Ganat, EL Calder, S Kriks, J Nelander, EY Tu, F Jia, D Battista, ...
The Journal of clinical investigation 122 (8), 2928-2939, 2012
Neural grafting in Parkinson’s disease: problems and possibilities
P Brundin, RA Barker, M Parmar
Progress in brain research 184, 265-294, 2010
Synaptic inputs from stroke-injured brain to grafted human stem cell-derived neurons activated by sensory stimuli
D Tornero, O Tsupykov, M Granmo, C Rodriguez, M Grønning-Hansen, ...
Brain 140 (3), 692-706, 2017
The system can't perform the operation now. Try again later.
Articles 1–20